ARx, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 400 Seaks Run Road, Glen Rock, Pennsylvania (PA) 17327, United States (USA)
- Operations here
- manufacturepack
- FDA identifiers
- FEI 2528933 · DUNS 806798018
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-06-03
- NAIDrug Quality Assurance2021-08-20
- VAIDrug Quality Assurance2019-03-29
- NAIDrug Quality Assurance2016-08-18
- NAIDrug Quality Assurance2014-02-18
- NAIDrug Quality Assurance2011-07-29
- VAIDrug Quality Assurance2010-12-03
- VAIDrug Quality Assurance2009-05-14
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Dexmedetomidinein shortageBioXcel Therapeutics, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.